Skip to Main content Skip to Navigation
Journal articles

CXCL5 drives obesity to diabetes, and further.: CXCL5 and metabolism

Abstract : We have recently shown that the CXCL5 chemokine is secreted by adipose tissue in the obese state. We demonstrated that adipose tissue-derived CXCL5 mediates insulin resistance in muscle. We speculate in this paper that CXCL5 could also mediate other obesity, and diabetes-derived pathologies, such as cardiovascular disease, retinopathy, or inflammatory bowel disease. In this scenario CXCL5 targeted therapy would prevent not only the development of type II diabetes in obese subjects, but also several other obesity-related co morbidities. Finally we propose to analyze the CXCL5 gene to find particular polymorphisms that could predict the development of type II diabetes in obese subjects.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-00469840
Contributor : Yves Le Ster Connect in order to contact the contributor
Submitted on : Friday, April 2, 2010 - 4:34:10 PM
Last modification on : Tuesday, March 15, 2022 - 9:32:10 AM
Long-term archiving on: : Wednesday, September 8, 2010 - 5:04:08 PM

Files

schema.pdf
Files produced by the author(s)

Identifiers

Citation

Carine Chavey, Lluis Fajas. CXCL5 drives obesity to diabetes, and further.: CXCL5 and metabolism. Aging, Impact Journals, 2009, 1 (7), pp.674-7. ⟨10.18632/aging.100064⟩. ⟨inserm-00469840⟩

Share

Metrics

Record views

111

Files downloads

315